These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4028583)

  • 1. [Biochemical studies on experimental chloroquine myopathy].
    Sano M
    Rinsho Shinkeigaku; 1985 May; 25(5):627-35. PubMed ID: 4028583
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental chloroquine myopathy--morphological and biochemical studies].
    Kumamoto T; Araki S; Toyoshima I; Fukuhara N
    Rinsho Shinkeigaku; 1984 May; 24(5):505-12. PubMed ID: 6478718
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental studies on the etiology of nitrofurane-induced polyneuropathy and histopathology of chlorochindiphosphate (Resochin) neuro-myopathy].
    Klinghardt GW
    Beitr Neurochir; 1970; 16():55-61. PubMed ID: 4246650
    [No Abstract]   [Full Text] [Related]  

  • 4. Skeletal muscle expression of clathrin and mannose 6-phosphate receptor in experimental chloroquine-induced myopathy.
    Masuda T; Ueyama H; Nakamura K; Jikumaru M; Toyoshima I; Kumamoto T
    Muscle Nerve; 2005 Apr; 31(4):495-502. PubMed ID: 15712280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental myopathies and muscular dystrophy. Studies in the formal pathogenesis of the myopathy of 2,4-dichlorophenoxyacetate.
    Heene R
    Schriftenr Neurol; 1975; 16():1-89. PubMed ID: 1226497
    [No Abstract]   [Full Text] [Related]  

  • 6. Trial of a cysteine proteinase inhibitor, EST, in experimental chloroquine myopathy in rats.
    Sugita H; Higuchi I; Sano M; Ishiura S
    Muscle Nerve; 1987; 10(6):516-23. PubMed ID: 3306368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental chloroquine myopathy: morphological and biochemical studies.
    Kumamoto T; Araki S; Watanabe S; Ikebe N; Fukuhara N
    Eur Neurol; 1989; 29(4):202-7. PubMed ID: 2759144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine myopathy.
    Hughes JT; Esiri M; Oxbury JM; Whitty CW
    Q J Med; 1971 Jan; 40(157):85-93. PubMed ID: 4253656
    [No Abstract]   [Full Text] [Related]  

  • 9. Chloroquine myopathy suggests that tau is degraded in lysosomes: implication for the formation of paired helical filaments in Alzheimer's disease.
    Oyama F; Murakami N; Ihara Y
    Neurosci Res; 1998 May; 31(1):1-8. PubMed ID: 9704973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine myopathy.
    Ionescu M; Alexianu M; Luca N; Petrovici A; Plăiaşu D; Voiculescu V
    Neurol Psychiatr (Bucur); 1975; 13(4):319-23. PubMed ID: 1224148
    [No Abstract]   [Full Text] [Related]  

  • 11. Accumulation of tau in autophagic vacuoles in chloroquine myopathy.
    Murakami N; Oyama F; Gu Y; McLennan IS; Nonaka I; Ihara Y
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):664-73. PubMed ID: 9690670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental myopathy induced with cortisone. Histological, histochemical and ultrastructural study].
    Toga M; Gambarelli D; Pellissier JF; Berard M; Hassoun J
    Ann Anat Pathol (Paris); 1973; 18(1):67-90. PubMed ID: 4716704
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemical studies in experimental chloroquine myopathy--preventive effect of E-64-d and physicochemical properties of liver autolysosomes].
    Sano M
    Rinsho Shinkeigaku; 1986 Mar; 26(3):205-14. PubMed ID: 3731622
    [No Abstract]   [Full Text] [Related]  

  • 14. Centronuclear myopathy: extraocular- and limb-muscle findings in an adult.
    Bergen BJ; Carry MP; Wilson WB; Barden MT; Ringel SP
    Muscle Nerve; 1980; 3(2):165-71. PubMed ID: 6445039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental chloroquine myopathy.
    Macdonald RD; Engel AG
    J Neuropathol Exp Neurol; 1970 Jul; 29(3):479-99. PubMed ID: 4247107
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental neuropathology and clinical neurology of chloroquine side effects.
    Klinghardt GW
    Int J Neurol; 1978; 11(4):331-41. PubMed ID: 397203
    [No Abstract]   [Full Text] [Related]  

  • 17. [Focal lesions of somatic musculature induced by dimethylparaphenylenediamine].
    Tsellarius SF
    Biull Eksp Biol Med; 1973 May; 75(5):116-9. PubMed ID: 4778675
    [No Abstract]   [Full Text] [Related]  

  • 18. Chloroquine myopathy and myasthenia-like syndrome.
    Sghirlanzoni A; Mantegazza R; Mora M; Pareyson D; Cornelio F
    Muscle Nerve; 1988 Feb; 11(2):114-9. PubMed ID: 3343986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of autophagy in glycogen breakdown and its relevance to chloroquine myopathy.
    Zirin J; Nieuwenhuis J; Perrimon N
    PLoS Biol; 2013 Nov; 11(11):e1001708. PubMed ID: 24265594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The therapeutic effect of cysteine proteinase inhibitor, EST, on experimental chloroquine myopathy].
    Higuchi I; Ishiura S; Sugita H; Ii K; Katunuma N
    Rinsho Shinkeigaku; 1986 Sep; 26(9):928-36. PubMed ID: 3491718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.